MMJ Group Holdings Ltd (ASX:MMJ) CEO Resignation
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) announces that its Chief Executive Officer Mr Jason Conroy has tendered his resignation.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) announces that its Chief Executive Officer Mr Jason Conroy has tendered his resignation.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update on the Company's activities as it transitions into full-scale domestic operations having secured almost all licencing and permitting required for its vertically integrated, Farm to Pharma business model.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2018. The Company's cash position at the end of the quarter stood at $1.5m. The Company also had $4,500,000 in deposits with terms of greater than 90 days. Expenditure during the quarter was in line with forecast.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached announcement by Harvest One Cannabis Inc. (CVE:HVT) (OTCMKTS:HRVOF) confirming that it has launched European sales of its recently reformulated Satipharm CBD capsules.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to provide an update on the unaudited market value of its investment portfolio (as at 29 January 2019).
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) has issued the attached notice to hold a meeting of MMJ shareholders on 22 February 2019 to approve, amongst other things, the launch of a share purchase plan ("SPP") as announced on 19 December 2018.
Anatara Lifesciences (ASX:ANR) is pleased to announce the appointment of Dr. David Brookes as Non-Executive Director and Chair of the Audit and Risk Committee, effective from 23 January 2019.